(Q77565327)

English

Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma

scientific article published on 01 September 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

based on heuristic

inferred from title

author name string

N L Berinstein

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

A J Grillo-López

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

C A White

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

I Bence-Bruckler

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

D Maloney

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M Czuczman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

D Green

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

J Rosenberg

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

P McLaughlin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

D Shen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 September 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

995-1001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Antibodies as cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosuppressive toxicity of CAMPATH1H monoclonal antibody in the treatment of patients with recurrent low grade lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 1a clinical trial of LYM-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008416911099

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008416911099

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818074%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77565327&oldid=1755162864"